A multi-omics approach to understand the influence of polyphenols in ovarian cancer for precision nutrition: a mini-review

被引:0
|
作者
Tecchio Borsoi, Felipe [1 ]
Ferreira Alves, Leticia [2 ]
Neri-Numa, Iramaia Angelica [1 ]
Geraldo, Murilo Vieira [2 ]
Pastore, Glaucia Maria [1 ]
机构
[1] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Dept Food Sci & Nutr,Lab Bioflavors & Bioact Cpds, Campinas, Brazil
[2] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Campinas, Brazil
基金
巴西圣保罗研究基金会;
关键词
Big data; high-throughput technologies; natural compounds; nutrigenetics; nutrigenomics; PERSONALIZED NUTRITION; GUT MICROBIOTA; BIG DATA; NUTRIGENOMICS; CELLS; FOOD; RESVERATROL; MODULATION; SIGNATURES; MUTATIONS;
D O I
10.1080/10408398.2023.2287701
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The impact of polyphenols in ovarian cancer is widely studied observing gene expression, epigenetic alterations, and molecular mechanisms based on new 'omics' technologies. Therefore, the combination of omics technologies with the use of phenolic compounds may represent a promising approach to precision nutrition in cancer. This article provides an updated review involving the current applications of high-throughput technologies in ovarian cancer, the role of dietary polyphenols and their mechanistic effects in ovarian cancer, and the current status and challenges of precision nutrition and their relationship with big data. High-throughput technologies in different omics science can provide relevant information from different facets for identifying biomarkers for diagnosis, prognosis, and selection of specific therapies for personalized treatment. Furthermore, the field of omics sciences can provide a better understanding of the role of polyphenols and their function as signaling molecules in the prevention and treatment of ovarian cancer. Although we observed an increase in the number of investigations, there are several approaches to data acquisition, analysis, and integration that still need to be improved, and the standardization of these practices still needs to be implemented in clinical trials.
引用
收藏
页码:1037 / 1054
页数:18
相关论文
共 50 条
  • [31] Multi-omics analysis of the prognosis and therapeutic significance of circadian clock in ovarian cancer
    Zhu, Jinyan
    Zhou, Qianyu
    Pan, Min
    Zhou, Cankun
    GENE, 2021, 788
  • [32] Integrating Rehabilomics into the Multi-Omics Approach in the Management of Multiple Sclerosis: The Way for Precision Medicine?
    Bonnechere, Bruno
    GENES, 2023, 14 (01)
  • [33] A multi-omics approach for identifying important pathways and genes in human cancer
    H. Robert Frost
    Christopher I. Amos
    BMC Bioinformatics, 19
  • [34] Identification of therapeutic targets of gallbladder cancer using multi-omics approach
    Ali, Asgar
    Ahmad, Ejaj
    Verma, Renu
    Sahu, Parameswar
    Nimisha
    Srivastava, Siddharth
    Saluja, Sundeep Singh
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2023, 22 (02) : 109 - 122
  • [35] Investigation of therapeutic networks in pancreatic cancer using multi-omics approach
    Kawabata, Reika
    CANCER SCIENCE, 2021, 112 : 320 - 320
  • [36] A multi-omics approach for identifying important pathways and genes in human cancer
    Frost, H. Robert
    Amos, Christopher I.
    BMC BIOINFORMATICS, 2018, 19
  • [37] Deep learning and multi-omics approach to predict drug responses in cancer
    Wang, Conghao
    Lye, Xintong
    Kaalia, Rama
    Kumar, Parvin
    Rajapakse, Jagath C.
    BMC BIOINFORMATICS, 2022, 22 (SUPPL 10)
  • [38] Deep learning and multi-omics approach to predict drug responses in cancer
    Conghao Wang
    Xintong Lye
    Rama Kaalia
    Parvin Kumar
    Jagath C. Rajapakse
    BMC Bioinformatics, 22
  • [39] Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
    He, Xiujing
    Liu, Xiaowei
    Zuo, Fengli
    Shi, Hubing
    Jing, Jing
    SEMINARS IN CANCER BIOLOGY, 2023, 88 : 187 - 200
  • [40] MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine
    Xie, Bingbing
    Yuan, Zifeng
    Yang, Yadong
    Sun, Zhidan
    Zhou, Shuigeng
    Fang, Xiangdong
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) : 625 - 632